| Patient | Benjamin Franklin |
|---|---|
| Date of birth | 1706-01-17 |
| Identifiers | MRN HR-EN004-SYN-TD; SSN (made up) 000-04-3318 |
| Document date | 1782-03-30 |
| Author | Mateo Ibarra, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Bladder stone with hematuria and obstructive voiding symptoms in a 76-year-old man with gout and stage 3a chronic kidney disease. Please confirm the diagnosis, remove the stone, look for its cause and for other sources of the bleeding, and advise on preventing recurrence. [S]
Urgency: Soon, within four weeks. [S]
Questions for the consultant:
Mr. Franklin is seen at the request of Dr. Penhallow for a bladder stone found on CT. For several years he has had a slow stream and nocturia, and for two months an interrupted stream, pain at the end of voiding that is worse after walking or car travel, and pink urine. He has had no fever, retention, or urinary infections. He has recurrent gout and started allopurinol four weeks ago. He has never smoked and has no history of pelvic radiation or occupational dye exposure. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrochlorothiazide 25 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1775-05-06 to 1782-03-02 | stopped | S |
| Losartan 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1782-03-02 | active | S |
| Allopurinol 100 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1782-03-02 to 1782-03-30 | completed | S |
| Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily | Two tablets by mouth daily | Oral route | 1782-03-30 to 1782-05-18 | completed | S |
| Colchicine 0.6 mg oral tablet, one tablet by mouth daily for flare prophylaxis | One tablet by mouth daily | Oral route | 1782-03-02 to 1782-09-14 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain, no more than 3 g a day | Two tablets every 6 hours as needed; maximum 6 tablets a day | Oral route | 1782-03-02 | active | S |
| Tamsulosin 0.4 mg oral capsule, one capsule by mouth at bedtime until surgery | One capsule by mouth at bedtime | Oral route | 1782-03-30 to 1782-04-20 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1782-03-30 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Gout with recurrent flares, mostly in the right big toe, without tophi; synthetic modern diagnosis linked to his documented gout | active | confirmed | M1A.0710 | S — Synthetic modern diagnosis; his recurrent gout is documented in his own letters (D). |
| Bladder stone (2.6 cm, uric acid on analysis) with bladder outlet obstruction, removed by cystolitholapaxy; synthetic modern diagnosis linked to his documented stone | resolved | confirmed | N21.0 | S — Synthetic modern diagnosis confirmed by CT and cystoscopy; his stone is documented in his own letters (D), though its composition is not known. |
| Chronic kidney disease stage G3a A1 | active | confirmed | N18.31 | S — Synthetic diagnosis; no measure of kidney function from his lifetime exists. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic diagnosis; no blood pressure from his lifetime exists. |
| Benign prostatic hyperplasia with lower urinary tract symptoms and bladder outlet obstruction, treated by transurethral resection | active | confirmed | N40.1 | S — Synthetic diagnosis made at the urology consultation as the probable cause of the bladder stone; the cause of his historical stone is not documented. |
Vital signs recorded on 1782-03-30; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| Abdomen | Mild suprapubic tenderness; bladder not palpable |
| Genitalia | Normal; no meatal stenosis |
| Rectal | Smooth, symmetric, moderately enlarged prostate, about 55 mL, without nodules |
| Cystoscopy | Single large mobile bladder stone; trabeculated bladder; obstructing lateral lobes with a median lobe; no bladder tumor or carcinoma in situ appearance |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1782-03-30 | Urate [Mass/volume] in Serum or Plasma | 7.6 | mg/dL | 3.5-7.2 mg/dL | High | S |
| 1782-03-30 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1782-03-30 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1782-03-30 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 24 | mmol/L | 22-29 mmol/L | Normal | S |
| 1782-03-30 | Urea nitrogen [Mass/volume] in Serum or Plasma | 21 | mg/dL | 8-23 mg/dL | Normal | S |
| 1782-03-30 | Creatinine [Mass/volume] in Serum or Plasma | 1.34 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1782-03-30 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1777)/1.73 sq M | 55 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 1782-03-30 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 1782-03-30 | US Urinary bladder Volume post void | 160 | mL | <=100 mL | High | S |
| 1782-03-30 | Maximum Urine flow by Uroflowmetry | 8.5 | mL/s | >=10 mL/s | Low | S |
| 1782-03-30 | International Prostate Symptom Score [IPSS] | 16 | {score} | S |
Data reviewed: The non-contrast CT, intake urinalysis, serum urate and kidney function, and today's IPSS, uroflowmetry, bladder ultrasound for residual, and office flexible cystoscopy. [S]